ADORA1 and Arrhythmia: The main advantage of this study was that we used the methods of network pharmacology and metabolomics correlation analysis to determine the pathways underlying the effects of PRP on arrhythmia and experimentally verified the key target ADORA1 and the main metabolites adenosine and cGMP in the pathway.